Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63,223,223
-
Total 13F shares
-
38,823,239
-
Share change
-
+327,524
-
Total reported value
-
$260,292,696
-
Price per share
-
$6.71
-
Number of holders
-
117
-
Value change
-
+$3,224,803
-
Number of buys
-
55
-
Number of sells
-
56
Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q3 2025
As of 30 Sep 2025,
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) was held by
117 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,823,239 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, BlackRock, Inc., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, VANGUARD GROUP INC, GAGNON SECURITIES LLC, MILLENNIUM MANAGEMENT LLC, CIBC Private Wealth Group LLC, JPMORGAN CHASE & CO, First Eagle Investment Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
117
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.